PIK3CA and neoplasm: Only four tumors (three MSS tumors and one MSI tumor, all in the training cohort) harbored PIK3CA mutation in both exons 9 and 20, which accounted for 0.5% of all studied samples and 4% of all mutated samples (Table2).